A detailed history of Janus Henderson Group PLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,336,516 shares of PEPG stock, worth $9.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,336,516
Previous 541,875 331.19%
Holding current value
$9.42 Million
Previous $8.65 Million 131.0%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.75 - $18.55 $13.9 Million - $33.3 Million
1,794,641 Added 331.19%
2,336,516 $20 Million
Q2 2024

Aug 14, 2024

SELL
$10.54 - $18.14 $6.59 Million - $11.3 Million
-624,767 Reduced 53.55%
541,875 $8.65 Million
Q1 2024

May 15, 2024

BUY
$6.63 - $17.3 $1.18 Million - $3.09 Million
178,438 Added 18.06%
1,166,642 $17.1 Million
Q4 2023

Feb 14, 2024

BUY
$3.86 - $7.96 $3.81 Million - $7.87 Million
988,204 New
988,204 $6.72 Million

Others Institutions Holding PEPG

About PepGen Inc.


  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $95.2M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.